A new vaccine has shown promise in preventing the return of a serious skin cancer. This vaccine is tailored to each patient, taking into account the unique characteristics of their tumor. It is being developed for people who have already had this type of cancer.

The vaccine uses a technology similar to that used in some coronavirus vaccines. It is being tested in combination with another treatment. Results from a major trial suggest that the vaccine can help stop the disease from coming back or spreading.

Further information on this vaccine and the trial results are available from the companies involved, Moderna and Merck.